Patents
Patents for C07D 333 - Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom (32,883)
07/2005
07/13/2005CN1639128A O-cyclopropyl-carboxanilides and their use as fungicides
07/13/2005CN1639099A Process for producing carbonyl compound
07/13/2005CN1638757A 组织蛋白酶半胱氨酸蛋白酶抑制剂 Cathepsin cystatin
07/13/2005CN1636998A Method for producing benzo annelated heterocycles
07/13/2005CN1636994A Process of preparing alkali metal salys of hydrophobic sulfonamides and alkali metal salt produced thereby
07/13/2005CN1636986A Benzophenones as inhibitors of reverse transcriptase
07/13/2005CN1636985A Benzophenones as inhibitors of reverse transcriptase
07/13/2005CN1636984A Benzophenones as inhibitors of reverse transcriptase
07/13/2005CN1636983A Substituted heterocyclic compounds
07/13/2005CN1636971A Oxime derivatives and the use thereof as latent acids
07/13/2005CN1636967A Noval compounds, their use and preparation
07/13/2005CN1636566A Medical uses of a selective estrogen receptor modulator in combination with sex steroid precursors
07/13/2005CN1636565A Modified form of the r(-)-n-(4, 4-di(3-methylthien-2-yl)but-3-enyl)-nipecotic acid hydrochloride
07/13/2005CN1636457A Fungicides for the control of take-all disease of plants
07/13/2005CN1210263C N-hydroxy-2-(alkyl, aryl or heteroaryl sulfanyl, sulfinyl or sulfonyl)-3-substituted alkyl, aryl or heteroarylamides as matrix metalloproteinase inhibitors
07/12/2005US6916957 Antiinflammatory agents; antihistamines; antiallergens
07/12/2005US6916956 Calcium receptor antagonist
07/12/2005US6916938 Method for preparing sulfone or sulfoxide compound
07/12/2005US6916848 Compounds for the treatment of metabolic disorders
07/12/2005US6916837 Such as 2-(6-amidino-2-naphthyloxy)-5-methanesulfonyl-aminobenzoic acid trifluoroacetate; blood coaggulation factor VII inhibitors
07/12/2005US6916835 Nitrate esters and their use for neurological conditions
07/12/2005US6916812 Dietetic agents
07/12/2005US6916797 α-arylethylpiperazine derivatives as neurokinin antagonists
07/12/2005US6916591 Comprises arylsulfonyloxime; for integrated circuits
07/12/2005US6916346 Primary intermediates for oxidative coloration of hair
07/07/2005WO2005061477A1 Biaryl sulfonamides as mmp inhibitors
07/07/2005WO2005061464A1 Herbicidal heteroaroyl-substituted phenylalanine amides
07/07/2005WO2005061459A1 Biaryl sulfonamides and methods for using same
07/07/2005WO2005061443A2 Benzoyl-substituted phenylalanine amides
07/07/2005WO2005060456A2 Method for treating adamts-5-associate disease
07/07/2005WO2005037810A3 Cyclopropyl methanone derivatives, the preparation and the therapeutic use thereof
07/07/2005WO2005032471A3 Benzylether and benzylamino beta-secretase inhibitors for the treatment of alzheimer's disease
07/07/2005WO2004048927A3 Second order nonlinear optical chromophores, polymers containing same, and electro-optic devices therefrom
07/07/2005US20050148648 Cystic fibrosis transmembrane conductance regulator; ABC transporter mediated diseases like cystic fibrosis; 5-methoxy-N-((1-(3,4-dimethoxyphenyl)-cyclohexyl)methyl)benzofuran-2-carboxamide; or sulfonamide analogs; chloride or bicarbonate channel modulators
07/07/2005US20050148638 Increasing contractile force in cardiac muscle fiber by administering a N-[(3-yloxy)-phenyl]-arylamide derivatives; modulating at the cardiac sarcomere (cardiac beta myosin) for congestive heart failure
07/07/2005US20050148629 Hydroxyamidealkylsulfonamide compounds for anthrax treatment
07/07/2005US20050148603 Compositions useful as inhibitors of protein kinases
07/07/2005US20050148595 heterocylcyclic amines used for treating or preventing conditions ameliorated by monoamine reuptake such as vasomotor symptoms, sexual dysfunction, gastrointestinal and genitourinary disorders, chronic fatigue syndrome, fibromylagia syndrome, nervous system disorders
07/07/2005US20050148584 N-(3-(2-(4-morpholino)ethyloxy)phenyl)-N-{(cis3-(benzylamino)cyclohexyl)methyl}-N'-phenylurea; useful for the treatment of gastrointestinal reflux disorders, eating disorders leading to obesity and irritable bowel syndrome
07/07/2005DE10358539A1 Carbonsäureamidderivate Carboxamide
07/07/2005CA2548518A1 Biaryl sulfonamides as mmp inhibitors
07/07/2005CA2548513A1 Biaryl sulfonamides and methods for using same
07/07/2005CA2548442A1 Benzoyl-substituted phenylalanine amides
07/07/2005CA2548354A1 Herbicidal heteroaroyl-substituted phenylalanine amides
07/07/2005CA2547814A1 Spiropiperidine derivatives for controlling pests
07/07/2005CA2547575A1 Method for treating adamts-5-associated disease
07/06/2005EP1550655A1 Bicyclic intermediates
07/06/2005EP1549655A2 Substituted bicyclic thiophene derivatives, compostions containing such compounds and methods of use
07/06/2005EP1549654A1 Process and intermediates for the preparation of thienopyrrole derivatives
07/06/2005EP1549653A1 Process and intermediates for the preparation of thienopyrrole derivatives
07/06/2005EP1549632A1 Novel thiophene amidines, compositions thereof, and methods of treating complement-mediated diseases and conditions
07/06/2005EP1549613A1 Sulfonamides having antiangiogenic and anticancer activity
07/06/2005EP1549607A2 Diastereoselective method of preparing olefins by means of the horner-wadsworth-emmons reaction, comprising the addition of a tris-(polyoxaalkyl)-amine sequestering agent
07/06/2005EP1549600A1 Ketones
07/06/2005EP1549304A1 Heterocyclic amides and their use in treating thromboembolic diseases and tumors
07/06/2005EP1216225B1 Novel derivatives of dicarboxylic acid having pharmaceutical properties
07/06/2005CN1634917A Method for removing corrosive impurity from inferior sulfolane
07/06/2005CN1634864A 9, 9-bis(triphenyl amino) fluorine derivatives and preparation and use thereof
07/05/2005CA2365585C Organic material undergoing light-induced phase transition
07/05/2005CA2199679C Dimethyl-(3-aryl-but-3-enyl)-amine compounds as pharmaceutical active ingredients
07/05/2005CA2151377C Aminomethylindans, -benzofurans and -benzothiophenes
06/2005
06/30/2005WO2005058884A2 Cyclopropane compounds and pharmaceutical use thereof
06/30/2005WO2005058867A1 Benzothiophene-and thiochromene containing phenethanolamine derivatives for the treatment of respiratory disorders
06/30/2005WO2005058866A1 Process for producing 2-acylthiophene compound
06/30/2005WO2005058808A1 N-substituted-n-sulfonylaminocyclopropane compounds and pharmaceutical use thereof
06/30/2005WO2005058299A1 Phenethanolamine derivatives for treatment of respiratory diseases
06/30/2005WO2005034878A3 Pyrovalerone analogs and therapeutic uses thereof
06/30/2005US20050143579 for the prevention and treatment of conditions ameliorated by monoamine reuptake including, inter alia, vasomotor symptoms (VMS), sexual dysfunction, gastrointestinal and genitourinary disorders, chronic fatigue syndrome, fibromylagia syndrome, nervous system disorders
06/30/2005US20050143426 Osteoporosis, bone disorders, or diseases associated with excessive secretion of PTH, such as hyperparathyroidism; reduce or inhibit parathyroid hormone (PTH) secretion
06/30/2005US20050143422 N-({4'-[(1-benzofuran-2-ylcarbonyl)amino]-1,1'-biphenyl-4-yl}sulfonyl)glycine; metalloproteinase inhibitors; arthritis, macular degeneration, graft versus host disease, cancer, osteoarthritis
06/30/2005US20050143385 Carbamic acid compounds comprising a piperazine linkage as hdac inhibitors
06/30/2005US20050142614 Methods for ligand discovery
06/30/2005US20050142155 Cytoprotective compounds, pharmaceutical and cosmetic formulations, and methods
06/30/2005US20050139822 A series of aromatic rings carrying a linear alkylene chain substituted with a polar group, e.g., 5-ethyl-5'''-(10-undecenyl)-2,2':5',2'':5'',2'''-quaterthiophene; thin films having the function of a dielectric layer and of a semiconductive layer; a self-assembled molecule (SAMS); low surface voltage
06/30/2005US20050139814 Benzofuran and benzothiophene derivatives useful in the treatmint of hyper-proliferative disorders
06/30/2005CA2549660A1 Cyclopropane compounds and pharmaceutical use thereof
06/30/2005CA2549598A1 N-substituted-n-sulfonylaminocyclopropane compounds and pharmaceutical use thereof
06/30/2005CA2544286A1 Process for producing 2-acylthiophene compound
06/29/2005EP1547996A1 Diagnostic probes and remedies for diseases with accumulation of prion protein, and stains for prion protein
06/29/2005EP1547603A2 Compositions and methods for use in targeting vascular destruction
06/29/2005EP1546371A1 Substrates for o6-alkylguanine-dna alkyltransferase
06/29/2005EP1546139A1 Derivative of dihydro-dibenzo (a) anthracenes and their use as selective estrogen receptor modulators
06/29/2005EP1546138A2 Novel raloxifene acid addition salts and/or solvates thereof, improved method for purification of said raloxifene acid addition salts and/or solvates thereof and pharmaceutical compositions comprising these
06/29/2005EP1546089A2 Aryl and heteroaryl compounds and methods to modulate coagulation
06/29/2005EP1546086A2 Aminoalcohol derivatives
06/29/2005EP1546077A2 Chiral diols, their manufacture and ligands and catalysts derived therefrom
06/29/2005EP1274701B1 [1,4']-bipiperidine compounds
06/29/2005EP1069122B1 PROCESS FOR PRODUCING 5-HYDROXYBENZO [b]THIOPHENE-3-CARBOXYLIC ACID DERIVATIVES
06/29/2005EP0901459B1 Calcilytic compounds
06/29/2005CN1633428A Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
06/29/2005CN1633427A Method for preparing chiral amines
06/29/2005CN1633426A 1, 3-dihydroxy benzene derivatives and coloring agent containing the same
06/29/2005CN1633410A Substituted methylene amide derivatives as modulators of protein tyrosine phosphatases(ptps)
06/29/2005CN1633296A Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
06/29/2005CN1631879A Substituted phenyl keto enols as pesticides and herbicides
06/29/2005CN1208329C Aniline derivatives
06/29/2005CN1208321C Fungicidal heterocyclic aromatic amides and their compositions, methods of use and preparation
06/28/2005US6911476 Useful for potentiating glutamate receptor function therefore useful for treating a wide variety of conditions, such as psychiatric and neurological disorders
06/28/2005US6911469 For therapy of disease treatable based on a blood sugar level-depressing activity or a disease treatable based on a cGMP-PDE inhibiting activity, smooth muscle relaxing activity, bronchodilating activity, vasodilating activity
06/28/2005US6911439 Alpha 4 beta 1 integrin and CD49d/ CD29 (vla-4); antiinflammatory agents